Pain And Fatigue Relief Tablet
NDC Package 43689-0015-2
Package Information
Pain And Fatigue Relief (aconitum napellus, arsenicum album, belladonna, coniinum, gelsemium sempervirens, hypericum perforatum, kali bichromicum, lacticum acidum, phosphoricum acidum, rhus tox, uricum acidum) tablets is temporarily relieves widespread aches, pains, and stiffness with fatigue Temporarily relieves widespread aches, pains, and stiffness with fatigue. This formulation utilizes a tablet delivery system. Marketed by The Magni Company, this product is identified by NDC 43689-0015.
Identification & Billing
Clinical Specifications
- ACONITUM NAPELLUS WHOLE 30 [hp_C]/1
- ARSENIC TRIOXIDE 30 [hp_C]/1
- ATROPA BELLADONNA 30 [hp_C]/1
- CONIINE 30 [hp_C]/1
- GELSEMIUM SEMPERVIRENS ROOT 30 [hp_C]/1
- HYPERICUM PERFORATUM WHOLE 3 [hp_X]/1
- LACTIC ACID, DL- 30 [hp_C]/1
- PHOSPHORIC ACID 30 [hp_C]/1
- POTASSIUM DICHROMATE 30 [hp_C]/1
- TOXICODENDRON PUBESCENS LEAF 30 [hp_C]/1
- URIC ACID 30 [hp_C]/1
Regulatory & Marketing
Hierarchy Structure
- 43689 - The Magni Company
- 43689-0015 - Pain And Fatigue Relief
- 43689-0015-2 - 1 BOTTLE in 1 CARTON / 125 TABLET in 1 BOTTLE (43689-0015-1)
- 43689-0015 - Pain And Fatigue Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43689-0015-2 identifies a specific commercial package of 1 bottle in 1 carton / 125 tablet in 1 bottle (43689-0015-1) of Pain And Fatigue Relief, a human over the counter drug labeled by The Magni Company. This tablet is formulated for oral use and contains aconitum napellus whole; arsenic trioxide; atropa belladonna; coniine; gelsemium sempervirens root; hypericum perforatum whole; lactic acid, dl-; phosphoric acid; potassium dichromate; toxicodendron pubescens leaf; uric acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Magni Company on June 12, 2015.
How is this The Magni Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43689001502. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.